1-3 of 3
Daniel Hicklin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Conditionally Activated IL-12 or IFNα Indukine™ Molecules Inhibit Syngeneic Lymphoma Tumor Growth in Mice, Induce Anti-Tumor Immune Responses and Are Tolerated in Non-Human Primates

Philipp Steiner, Heather Brodkin, Josue Canales, Daniel Hicklin, Randi Isaacs, Nesreen Ismail, Kristin Morris, Christopher Nirschl, Andres Salmeron, Cindy Seidel-Dugan, Zoe Steuert, Jenna Sullivan, Ethika Tyagi, William Winston
Journal: Blood
Blood (2021) 138 (Supplement 1): 2258.
https://doi.org/10.1182/blood-2021-152758
Published: 2021
Journal Articles

Supression of FLT3-Expressing Leukemia by a Monoclonal Antibody-Auristatin Conjugate.

Yiwen Li, MD, Hongli Li, Mei-Nai Wang, Rajiv Bassi, Dale Ludwig, PhD, Larry Witte, PhD, Zhenping Zhu, MD, PhD, Peter Bohlen, PhD, Damon Meyer, PhD, Angelyn Larkin, Peter Senter, PhD, Daniel Hicklin, PhD
Journal: Blood
Blood (2004) 104 (11): 1788.
https://doi.org/10.1182/blood.V104.11.1788.1788
Published: 2004
Journal Articles

Induction of cutaneous delayed-type hypersensitivity reactions in VEGF-A transgenic mice results in chronic skin inflammation associated with persistent lymphatic hyperplasia

Rainer Kunstfeld, Satoshi Hirakawa, Young-Kwon Hong, Vivien Schacht, Bernhard Lange-Asschenfeldt, Paula Velasco, Charles Lin, Edda Fiebiger, Xunbin Wei, Yan Wu, Daniel Hicklin, Peter Bohlen, Michael Detmar
Journal: Blood
Blood (2004) 104 (4): 1048–1057.
https://doi.org/10.1182/blood-2003-08-2964
Published: 2004